According to Cognyte Software's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.75857. At the end of 2023 the company had a P/S ratio of 0.9330.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.9330 | 83.87% |
2022 | 0.5074 | -81.95% |
2021 | 2.81 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Abiomed ABMD | 16.0 | 809.57% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | 19.6 | 1,011.76% | ๐บ๐ธ USA |
Cormedix CRMD | N/A | N/A | ๐บ๐ธ USA |
Nevro
NVRO | 0.7887 | -55.15% | ๐บ๐ธ USA |